Key result
Ischemic preconditioning failed to reduce infarct size in focal adhesion kinase knockout mice compared to nonpreconditioned controls (37.1% vs 43.7% and 44.7%, P=NS).
Why the study?
Does ischemic preconditioning reduce infarct size in adult murine hearts with conditional knockout of myocyte focal adhesion kinase?
Does ischemic preconditioning reduce infarct size in adult murine hearts with conditional knockout of myocyte focal adhesion kinase?
Absolute Event Rate: 37.1% vs 43.7%
p-value: p=NS
Focal adhesion kinase is an essential mediator of ischemic preconditioning-elicited cardioprotection in adult murine hearts, supporting the role of cytoskeletal-based survival signaling.
Focal adhesion kinase mediates preconditioning cardioprotection in adult murine hearts; hypothesis-generating for cytoskeletal signaling in clinical translation.
BACKGROUND: Our laboratory has previously demonstrated the importance of a cytoskeletal-based survival signaling pathway using in vitro models of ischemia/reperfusion (IR). However, the importance of this pathway in mediating stress-elicited survival signaling in vivo is unknown. METHODS AND RESULTS: The essential cytoskeletal signaling pathway member focal adhesion kinase (FAK) was selectively deleted in adult cardiac myocytes using a tamoxifen-inducible Cre-Lox system (α-MHC-MerCreMer). Polymerase chain reaction (PCR) and Western blot were performed to confirm FAK knockout (KO). All mice were subjected to a 40-minute coronary occlusion followed by 24 hours of reperfusion. Ischemic preconditioning (IP) was performed using a standard protocol. Control groups included wild-type (WT) and tamoxifen-treated α-MHC-MerCreMer+/-/FAK(WT/WT) (experimental control) mice. Infarct size was expressed as a percentage of the risk region. In WT mice IP significantly enhanced the expression of activated/phosphorylated FAK by 36.3% compared to WT mice subjected to a sham experimental protocol (P ≤ 0.05; n = 6 hearts [sham], n = 4 hearts [IP]). IP significantly reduced infarct size in both WT and experimental control mice (43.7% versus 19.8%; P ≤ 0.001; 44.7% versus 17.5%; P ≤ 0.001, respectively). No difference in infarct size was observed between preconditioned FAK KO and nonpreconditioned controls (37.1% versus 43.7% versus 44.7%; FAK KO versus WT versus experimental control; P=NS). IP elicited a 67.2%/88.8% increase in activated phosphatidylinositol-3-kinase (PI3K) p85/activated Akt expression in WT mice, but failed to enhance the expression of either in preconditioned FAK KO mice. CONCLUSIONS: Our results indicate that FAK is an essential mediator of IP-elicited cardioprotection and provide further support for the hypothesis that cytoskeletal-based signaling is an important component of stress-elicited survival signaling.
No takes yet. Share an insight, caveat, or question.
Perricone et al. (2013) studied Ischemia/reperfusion injury. Ischemic preconditioning in FAK knockout mice vs. Nonpreconditioned controls and wild-type mice was evaluated on Infarct size as a percentage of the risk region (p=NS). Ischemic preconditioning failed to reduce infarct size in focal adhesion kinase knockout mice compared to nonpreconditioned controls (37.1% vs 43.7% and 44.7%, P=NS).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: